Magnetar Financial’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Magnetar Financial’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75,537	Closed	-$758K	–	1583
2021 Q4	$758K	Buy	75,537 +17,693	+31%	+$181K	0.01%	874
2021 Q3	$589K	Sell	57,844 -1,680,365	-97%	-$16.9M	0.01%	850
2021 Q2	$17.4K	Buy	1,738,209 +15,109	+0.9%	+$153K	0.17%	127
2021 Q1	$17.3M	Buy	1,723,100 +23,100	+1%	+$246K	0.17%	121
2020 Q4	$17.9M	Buy	+1,700,000	New	+$17.7M	0.25%	81

Other funds holding MTACU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial's MTACU Position: Q1 2022 in Review

Magnetar Financial sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2022, closing a stake of 75,537 shares — an estimated $758K sold.

Magnetar Financial first reported a position in MTACU in Q4 2020 and held it in 5 quarters. The position peaked at $17.9M in Q4 2020. 5 funds tracked by Wall St. Rank hold MTACU as of Q1 2022.

Magnetar Financial reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
Magnetar Financial sold 75,537 MedTech Acquisition Corporation Unit shares in Q1 2022, an estimated $758K.
Magnetar Financial first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 5 quarters.
Magnetar Financial's MedTech Acquisition Corporation Unit position peaked at $17.9M in Q4 2020.
5 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2022.

Based on Magnetar Financial's 13F filing for Q1 2022, filed 16 May 2022.